ClinConnect ClinConnect Logo
Search / Trial NCT04560140

Promoting Community Reintegration for Young Adults With Stroke

Launched by CHINESE UNIVERSITY OF HONG KONG · Sep 17, 2020

Trial Information

Current as of August 20, 2025

Recruiting

Keywords

Stroke Community Reintegration Narrative Skill Building

ClinConnect Summary

This clinical trial is studying a program designed to help young adults who have survived a stroke reintegrate into their communities and improve their overall well-being. The program includes storytelling and skill-building activities to support their adjustment after leaving the hospital. Researchers want to see how effective this approach is in both the short and long term for young stroke survivors.

To be eligible for this trial, participants must be between 18 and 64 years old, have had a stroke, and be living at home after their hospital stay. They should also be able to communicate in Cantonese and attend all scheduled sessions. Participants will engage in the intervention program, and their experiences and progress will be tracked throughout the study. This trial is currently recruiting participants, and it offers a unique opportunity to contribute to important research that could benefit young stroke survivors in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • (1) are 18-64 years of age,
  • (2) have a clinical diagnosis of first-ever or recurrent ischaemic or haemorrhagic stroke,
  • (3) are living at home after discharge from hospital,
  • (4) have a Montreal Cognitive Assessment score \>20,
  • (5) have a modified Rankin Scale score ≥3,
  • (6) can communicate in Cantonese, and
  • (7) are able to attend all intervention sessions.
  • Exclusion Criteria:
  • 1) transient ischaemic attack, subdural or epidural haemorrhage,
  • 2) experienced cerebrovascular events due to tumours or head trauma,
  • 3) mental condition such as depression, schizophrenia, bipolar or personality disorder,
  • 4) incomprehensible speech or difficulty in comprehending conversations, or
  • 5) have received a self-management programme in the past.

About Chinese University Of Hong Kong

The Chinese University of Hong Kong (CUHK) is a prestigious research institution renowned for its commitment to advancing medical science and improving healthcare outcomes. As a clinical trial sponsor, CUHK leverages its extensive academic resources and interdisciplinary expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among leading researchers, healthcare professionals, and industry partners, ensuring rigorous study design and implementation. CUHK is dedicated to upholding the highest ethical standards in clinical research, with a focus on translating findings into tangible benefits for patients and the broader community.

Locations

Hong Kong, , Hong Kong

Patients applied

0 patients applied

Trial Officials

Suzanne Lo

Principal Investigator

Chinese University of Hong Kong

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials